Target Name: MIR30C1
NCBI ID: G407031
Review Report on MIR30C1 Target / Biomarker Content of Review Report on MIR30C1 Target / Biomarker
MIR30C1
Other Name(s): hsa-miR-30c-5p | microRNA 30c-1 | MIRN30C1 | MicroRNA 30c-1 | hsa-mir-30c-1 | hsa-miR-30c-1-3p | mir-30c-1

Understanding The Potential Applications of MIR30C1

MIR30C1, also known as hsa-miR-30c-5p, is a non-coding RNA molecule that has been shown to play a role in various biological processes. One of the most promising aspects of MIR30C1 is its potential as a drug target or biomarker . In this article, we will explore the biology and potential applications of MIR30C1.

MIR30C1 is a microRNA (miRNA), a small non-coding RNA molecule that plays a critical role in post-transcriptional gene regulation. MiRNAs are designed to target specific mRNAs for degradation, and their levels can be regulated by various factors, including microRNA targets , messenger RNA (mRNA), and degradation factors.

MIR30C1 is a non-coding RNA molecule that contains 29 amino acid residues and has a calculated molecular weight of 30.4 kDa. It is expressed in various tissues and cells, including brain, heart, liver, and placenta. MIR30C1 is predominantly expressed in the cytoplasm of cultured cells and has been shown to be predominantly in the cytoplasm in live cells.

MIR30C1 has been shown to play a role in various biological processes, including cell growth, apoptosis, and metabolism. One of the most promising aspects of MIR30C1 is its potential as a drug target.

Drug discovery is a challenging process that requires the identification of small molecules that can interact with a specific target protein. The use of MIR30C1 as a drug target is promising because of its unique biology and the diverse range of biological processes it is involved in.

MIR30C1 has also been shown to play a role in the regulation of metabolism. including the regulation of glucose metabolism.

In addition to its role in cell growth and metabolism, MIR30C1 has also been shown to play a role in the regulation of apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells. The regulation of apoptosis by MIR30C1 has has been shown to play a role in the maintenance of tissue homeostasis and the regulation of multicellular processes.

MIR30C1 has also been shown to play a role in the regulation of stem cell biology. MIR30C1 has been shown to be involved in the regulation of stem cell self-renewal and the maintenance of stem cell stem cell.

In addition to its role in stem cell biology, MIR30C1 has also been shown to play a role in the regulation of tissue repair and regeneration. MIR30C1 has been shown to be involved in the regulation of the Wnt signaling pathway, which is involved in the regulation of tissue repair and regeneration.

MIR30C1 has also been shown to play a role in the regulation of inflammation. MIR30C1 has been shown to be involved in the regulation of the NF-kappa-B signaling pathway, which is involved in the regulation of inflammation.

In conclusion, MIR30C1 is a non-coding RNA molecule that has been shown to play a role in various biological processes, including cell growth, apoptosis, and metabolism. Its potential as a drug target is currently being investigated for the treatment of various diseases, including cancer, diabetes, and cardiovascular disease. Further research is needed to fully understand the biology and potential applications of MIR30C1.

Protein Name: MicroRNA 30c-1

The "MIR30C1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR30C1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188